Browse > Article

Effects of Interleukin-$1\beta$, Tumor Necrosis Factor-$\alpha$ and Interferon-$\gamma$ on the Nitric Oxide Production and Osteoclast Generation in the Culture of Mouse Bone Marrow Cells  

Kwon, Young-Man (Dept. of Oral Biochemistry, Dankook University)
Kim, Se-Won (Dept. of Dental Pharmacology, Dankook University)
Ko, Seon-Yle (Dept. of Oral Biochemistry, Dankook University)
Publication Information
International Journal of Oral Biology / v.31, no.2, 2006 , pp. 67-72 More about this Journal
Abstract
Nitric oxide(NO) is a labile, uncharged, reactive radical that functions as a sensitive mediator of intercellular communication in diverse tissues. It has been reported that NO is produced by osteoblast and these results may suggest that NO is integrally involved in the regulation of osteoclast formation and osteoclast resorption activity by osteoblastic cells. We examined the effect of cytokines on NO release by mouse bone marrow cell. We also examined the effects of cytokines and sodium nitroprusside(SNP) on the formation of osteoclast-like cell from mouse bone marrow cells in culture. Cytokines stimulated NO production of mouse bone marrow cells, and N-nitro-L-arginine methyl ester, a specific inhibitor of NO synthase, suppressed the cytokine-induced NO production. SNP showed dual action in the generation of osteoclasts. The addition of $30{\mu}M$ SNP inhibited the formation of tartrate resistant acid phosphatase(TRAP)(+) multinucleated cell, whereas lower concentration($3{\mu}M$) of SNP enhanced it. Although the precise action of NO remains to be elucidated in detail, the action of NO in osteoclast generation in our studies seems to be associated, at least in part, with bone metabolism and bone pathophysiology.
Keywords
$IL-1\beta$; $TNF-\alpha$; NO; osteoclast;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. and Kudo, A.: Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Cell. Biol. 275: 4858-4864, 2000
2 Barman, S.A.: Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle. Lung 183: 325-335, 2005   DOI
3 Cohen, R.I., Wilson, D. and Liu, S.F: Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both guanosine-3',5'(cyclic) phosphate-dependent and independent pathways. Crit. Care. Med. 34:173-181, 2006   DOI   ScienceOn
4 Gowen, M., Wood, D.D., Ihrie, E.J, McGuire, M.K.B. and Russel, R.GG: An interleukin-1 like factor stimulates bone resorption in vitro. Nature 306: 378-380, 1983   DOI   ScienceOn
5 Minkin, C.: Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34:285-290, 1982   DOI
6 Palmer, R.M.J., Andrews, T., Foxwell, N.A. and Moncada, S.: Glucocorticoids do not affect the induction of a novel calcium dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun. 188: 209-215,1992   DOI   ScienceOn
7 Punjabi, C.J., Laskin, D.L., Heck, D.E. and Laskin, J.D.: Production of nitric oxide by murine bone marrow cells. J. Immunol. 149: 2179-2184, 1992
8 Raisz, L.G: Hormonal regulation of bone growth and remodeling. in Cell and. Molecular Biology of Vertebrate Hard Tissue CIBA Foundation Symposium 136, pp 226-238, Wiley, New York, 1988
9 Ralston, S.H., Helfrich, M.H., Grabowski, P.S. and Benjamin, N.: A role for nitric oxide in the regulation of cytokineinduced bone resorption J. Bone Miner. Res. (Suppl 1) 8: 383(abstract), 1993
10 Stem, P.H. and Diamond, J.: Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bone. Res. Commun. Chem. Pathol. Pharmacol. 75: 19-27, 1992
11 Thompson, B.M., Mundy, G.R. and Chambers, T.J.: Tumor necrosis factors $\alpha$ and $\beta$ induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138: 775-779, 1987
12 Srivastava, S., Toraldo, G, Weitzmann, M.N., Cenci, S., Ross, E.P. and Pacifici, R.: Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappaB ligand(RANKL)-induced JNK activation. J. Biol. Chem. 276:8836-8840,2001   DOI   ScienceOn
13 Tatakis, D.N.: Interleukin-l bone metabolism: A review. J. Periodontol. 64: 416-431,1993
14 Zaidi, M., Alam, A.S., Bax, B.E., Shankar, V.S., Bax, C.M., Gill, J.S., Pazianas, M., Huang, C.L., Sahinoglu, T., Moonga, B.S., Stevens, C.R. and Blake, D.R.: Role of the endothelial cell in osteoclast control: New perspectives. Bone 14: 97102, 1993
15 Cenci, S., Weitzmann, M.N., Roggia, C., Namba, N., Novack, D., Woodring, land Pacifici, R.: Estrogen deficiency induces bone loss by enhancing T-cell production of TNFalpha. J Clin. Invest. 106: 1229-1237, 2000   DOI   ScienceOn
16 Kanematsu, M., Sato, T, Takai, H., Watanabe, K., Ikeda, K. and Yamada, Y.: Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand on pre-B cells: implicationf for accelerated osteoclastogenesis in estrogen defiency. J. Bone Miner. Res. 15: 1321-1329, 2000   DOI   ScienceOn
17 Lowenstein, C.J. and Snyder, S.H.: Nitric oxide, a novel biological messenger. Cell 70: 705-707. 1992   DOI   ScienceOn
18 Nussler, A.K, DiSilvio, M., Billiar, T.R., Hoffman, R.A, Geller D.A, Selby, R., Madrigas, J. and Simmons, R.L.: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176: 261-264,1992   DOI   ScienceOn
19 Nicholson, A.G, Haites, N.E., Mckay, N.G, Wilson, H.M., MacLeod, A.M. and Benjamin, N.: Induction of nitric oxide synthase in human mesangial cells. Biochem. Biophys. Res. Commun. 193: 1269-1274, 1993   DOI   ScienceOn
20 Ralston, S.H., Ho, L.P., Helfrich, M.H., Grabowski, P.S., Johnston, P.W. and Benjamin, N.: Nitric oxide: A cytokineinduced regulator of bone resorption J. Bone Miner. Res. 10: 1040-1049, 1995   DOI   ScienceOn
21 Collin-Osdoby, P., Rothe, L., Anderson, F., Nelson, M., Maloney, W. and Osdoby, P.: RANKL and OPG expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem. 276: 20659-20672, 2001   DOI   ScienceOn
22 Ding, A., Nathan, C.F. and Stuehr, D.J.: Release of reactive nitrogen intermediates and reacrive oxygen intermediate from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407, 1988
23 MacIntyre, I., Zaidi, M., Towhidul, Alam, A.S.M., Datta, H.K., Moonga, B.S., Kidbury, P.S., Hecker, M. and Vane, J.M.: Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA 88: 2936-2940,1991
24 Lowik, W.G.M.C., Nibbering, P.H., Van der Ruit, M. and Papapoulos, S.E.: Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J. Clin. Invest. 93: 1465-1472, 1994   DOI   ScienceOn
25 Dewhirst, F.E., Stashenko, P. P., Mole, J.E. and Tsurumachi, T.: Purification and partial sequence of human osteoclastactivating factor: Identity with interleukin 1$\beta$. J. Immunol. 135:2562-2568, 1985
26 Fan, X., Roy, E., Zhu, L., Murphy, T.C., Ackert-Bicknell, C., Hart, C.M., Rosen, C., Nanes, M.S. and Rubin, J.: Nitric oxide regulates RANKL and OPG expression in bone stromal cells, Endocrinology 145: 1-9, 2004   DOI
27 Stefanovic-Racic, M., Stadler, J. and Evans, C.H.: Nitric oxide and arthritis. Arth. Rheum. 36: 1036-1044, 1993   DOI   ScienceOn
28 Freeman, B.: Free radical chemistry of nitric oxide. Chest 105(suppl): 79s-84s, 1994   DOI
29 Mundy, G.R. and Roodman, G.D.: Osteoclast ontogeny and function, In Bone and Mineral Research, vol. 5, edited by Peck, W.A, pp 209-279, Elsevier, Amsterdam, 1987
30 Scheven, B.A.A., Visser, J.W.M. and Nijweide, P.J.: In vitro osteoclast generation from different bone marrow fractions, including a highly enriched hematopoietic stem cell population. Nature 321: 79-81, 1986   DOI   ScienceOn
31 Kwak, H.J., Song, J.S., No, Z.S., Song, J.H., Yang, S.D. and Cheon, H.G: The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res. 54: 508-513, 2005   DOI
32 van't Hof, R.J. and Ralston, S.H.: Nitric oxide and bone, Immunology 103:255-261,2001   DOI
33 Hofbauer, L.C.: Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur. J Endocrinol. 141:195-210,1999   DOI
34 Hibbs, J.B., Traintor, R.R., Vavrin, Z. and Rachlin, E.M.: Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94, 1988   DOI   ScienceOn
35 Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, m., Kotake, S., Nakagawa, N., Kinisaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashino, K., Martin, T.J. and Suda, T.: Tumor necosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-286, 2000   DOI
36 Rubin, J., Murphy, T.C., Zhu, L., Roy, E., Nanes, M.S. and Fan, X: Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERKl/2 MAPK. J. Biol. Chem. 278: 34018?34025, 2003   DOI   ScienceOn
37 Suda, T., Takahashi, N. and Martin, T.J.: Modulation of osteoclast differentiation. Endocrine. Rev. 13: 66-80, 1992
38 Kasten, T.P., Collin-Osdoby, P., Patel, N., Osdoby, P., Siegel, N.R., Misko, TP., Currie, M.G and Nickols, GA.: Potentiation of osteoclastic bone resorbing activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91: 3569-3573,1994
39 Thomson, B.M., Saklatvala, J. and Chambers, T.J.: Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclast. J. Exp. Med. 164: 104-112, 1986   DOI
40 Romas, E., Sims, N.A., Hards, D.K., Lindsay, M., Quinn, J.W., Ryan, P.E, Dunstan, C.R., Martin, T.J. and Gillespie, M.T.: Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am. J. Pathol. 161 :1419-1427, 2002   DOI   ScienceOn
41 Howard, G,A.: Basic and clinical research, in Normal and abnormal bone growth, edited by Dixon, A.D. and Sarnat, B.G, pp 67-76, New York, Alan RLiss, 1985
42 Anderson, D.M., Maraskovsky, E., Billingsley, W.L.: Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F, Cosman, D. and Galibert, L.:A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390: 175-179, 1997   DOI   ScienceOn
43 Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D. and Mundy, G.R.: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516-518, 1986   DOI   ScienceOn
44 Collin-Osdoby, P., Nickols, G.A. and Osdoby, P.: Bone cell function, regulation, and communication: A role for nitric oxide. J. Cell. Biochem. 57: 399-408, 1995   DOI   ScienceOn
45 McCall, T.R, Boughton-Smith, N.K., Palmer, R.M.J., Whittle, R.J.R. and Moncada, S.: Synthesis of nitric oxide from Larginine by neutrophils, Biochem. J. 261: 293-296, 1989   DOI
46 Ignarro, L.J.: Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension 16:477-483, 1990   DOI